Product Pipeline

Protemix has a broad product pipeline with compounds that work across a range of treatment areas for diabetes disorders and complications. Protemix has completed four Phase 2 human clinical trials of lead compound PX811019.

RESEARCH &
DISCOVERY
PRE
CLINICAL
PHASE 1
PHASE 2
PHASE 3
PX811019
PX811013
EN122004
PX811016
Email Page | Print Page Contact Protemix | Site Map |
  Search
©2010 Protemix Corporation Limited | Privacy Statement | Terms of Use